Method of treating Alzheimer's disease
First Claim
Patent Images
1. A method comprising orally administering an oral formulation to a patient having Alzheimer'"'"'s disease, daily and for a period of at least six weeks, the oral formulation comprising about 12 mg to about 40 mg azelastine or a pharmaceutically acceptable salt of azelastine, thereby improving the patient'"'"'s quality of life as demonstrated by the patient requiring less need for support with the patient'"'"'s activities of daily living.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods of treating patients suffering from or exhibiting symptoms of mental, behavioral, and/or cognitive disorders with azelastine or a pharmaceutically acceptable salt of azelastine is disclosed.
-
Citations
9 Claims
- 1. A method comprising orally administering an oral formulation to a patient having Alzheimer'"'"'s disease, daily and for a period of at least six weeks, the oral formulation comprising about 12 mg to about 40 mg azelastine or a pharmaceutically acceptable salt of azelastine, thereby improving the patient'"'"'s quality of life as demonstrated by the patient requiring less need for support with the patient'"'"'s activities of daily living.
- 6. A method comprising orally administering an oral formulation to a patient having Alzheimer'"'"'s disease, the oral formulation comprising about 12 mg to 40 mg azelastine or a pharmaceutically acceptable salt of azelastine, whereby the oral formulation is administered daily and for a period of time to improve one or more symptoms of the patient'"'"'s Alzheimer'"'"'s disease as measured by Mini-Mental State Examination (MMSE).
Specification